Resonetics, LLC

Resonetics, LLC is a specialized provider of advanced engineering and manufacturing solutions for the MedTech and life sciences sectors, focusing on intricate medical device fabrication and product development. Founded in 1987 and headquartered in Nashua, US, Resonetics, LLC is dedicated to engineering and manufacturing solutions for the medical technology sector. The company has not undergone any significant pivots in its business strategy. It has completed a total of 4 deals, with the most recent deal occurring on December 3, 2021.

The founder’s history and other specific details about previous companies are not publicly available. Resonetics specializes in advanced engineering, product development, prototyping, and micro-manufacturing solutions tailored for the MedTech and life sciences sectors. The company's core product offerings include the fabrication of intricate medical devices, diagnostic tools, and sensor technologies. Their services encompass quick-turn catheter shafts, laser cutting and welding, nitinol processing, and custom laser systems, all aimed at accelerating the development and market entry of innovative medical devices.

Resonetics serves a diverse clientele, including medical device manufacturers and healthcare organizations, primarily targeting markets in North America, Europe, and Asia. The end users of these products and services include healthcare providers, researchers, and patients who benefit from improved medical technologies and diagnostics. Resonetics generates revenue through direct B2B transactions with its clients, typically involving contracts for custom manufacturing services and product development partnerships. The company's pricing structure is based on project scope and complexity, often tailored to meet specific client needs, encompassing both fixed-fee arrangements and variable pricing models depending on the volume and nature of services rendered.

Notable offerings, such as their laser processing technologies and sensor solutions, are integral to many of the contracts they secure. Revenue is derived from a combination of one-time project fees and ongoing partnerships, allowing clients to leverage Resonetics' expertise in bringing advanced medical solutions to market efficiently. Following the acquisition of a 50% majority stake by Carlyle Group and GTCR from Sverica on December 3, 2021, Resonetics, LLC is positioned to accelerate its growth strategy and strengthen its manufacturing solutions. The funding will support the company's efforts to expand across global markets through organic add-ons.

Specific new products are currently in development, and the company plans to target expansion into new geographical regions aimed at enhancing its global presence in the MedTech sector.